Showing results (61-70 of 540) with videos related to

Sort By:
Pageof 54
Autoimmunity Reviews|December 2, 2006
The catastrophic antiphospholipid (Asherson's) syndrome and malignanciesW Miesbach, R A Asherson, R Cervera, et al.
Lupus|January 1, 1997
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapyF J Muñoz-Rodríguez, J Font, J R Badia, et al.
Clinical and Experimental Rheumatology|October 6, 1997
Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?C Miret, R Cervera, J C Reverter, et al.
Clinical and Experimental Immunology|December 22, 1999
Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)J Font, P Pizcueta, M Ramos-Casals, et al.
The Journal of Rheumatology|January 27, 2000
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patientsJ Rojas-Rodriguez, M Garcia-Carrasco, M Ramos-Casals, et al.
QJM : Monthly Journal of the Association of Physicians|February 13, 2001
Cardiovascular risk factors and the long-term outcome of lupus nephritisJ Font, M Ramos-Casals, R Cervera, et al.
Annals of the Rheumatic Diseases|February 1, 1990
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patientsR Cervera, J Font, A López-Soto, et al.
Medicina Clinica|April 23, 1994
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]J Vivancos, A López-Soto, J Font, et al.
Lupus|February 1, 1995
Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosusJ Font, J Vidal, R Cervera, et al.
Clinical Rheumatology|December 1, 1989
Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associationsJ Font, R Cervera, A Lopez-Soto, et al.
Pageof 54